Preventing lung cancer requires a combination of lifestyle, environmental, and clinical measures aimed at reducing exposure to known risk factors and promoting early detection. Tobacco use remains the single largest contributor to lung cancer, making smoking cessation programs a cornerstone of prevention. These programs include counseling, pharmacologic aids, nicotine replacement therapy, and public awareness campaigns to discourage initiation and support cessation. In addition, minimizing exposure to secondhand smoke, occupational carcinogens such as asbestos or diesel fumes, and environmental pollutants is essential to lower risk. Genetic predisposition and pre-existing lung conditions also influence individual susceptibility, highlighting the need for personalized prevention approaches.
Screening and early detection play a vital role in preventing advanced disease. Low-dose computed tomography (LDCT) screening in high-risk populations allows for identification of early-stage lung cancers that can be treated more effectively, improving survival rates. Public health initiatives, including education about symptom awareness and regular health check-ups, support timely medical evaluation. Lifestyle interventions such as maintaining a balanced diet rich in fruits and vegetables, engaging in regular physical activity, and managing chronic respiratory conditions further contribute to lowering risk. At the policy level, regulatory measures to control air pollution, enforce workplace safety, and reduce tobacco availability are critical. Comprehensive lung cancer prevention strategies integrate individual behavior modification, community health initiatives, and policy enforcement to reduce incidence, promote early diagnosis, and enhance overall population respiratory health
Title : Novel signaling mechanisms and innovative therapeutic strategies of pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Changing population immunity to COVID-19 in the context of infection, vaccination and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Susceptibility to SARS-CoV-2 infection and nasal air conditioning ability
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Comparative evaluation of DECAF and BAP 65 scores in predicting outcomes of COPD exacerbations among in patients at Vicente Sotto Memorial Medical Center
Allanys Joy Q Pino, Vicente Sotto Memorial Medical Center, Philippines
Title :
Saurabh Chattopadhyay, University of Kentucky College of Medicine, United States
Title : Personalized and precision Medicine (PPM) as a unique healthcare model through biodesign driven and inspired biotech, translational applications and pulmonology related marketing to secure the human healthcare, wellness and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation